Pharmafile Logo

AmerisourceBergen Specialty Group – ABSG

For pharmaceutical manufacturers and healthcare providers, AmerisourceBergen Specialty Group is an essential business partner. We lead the market in biotechnology, plasma derivative and oncology product distribution. Pharmaceutical manufacturers rely on us for services like outsourced logistics and market access programs that support commercialization strategies. We provide the resources physicians need to maximize practice efficiency and the specialty pharmacy services patients need to improve their health.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

3101 Gaylord Parkway, Frisco, TX, 75034, United States
+1 866-408-3761

 Latest Content from PMHub 

Wanda Lesowiec did it. Could you?

How a background in pharma can mean a bright future in medical communications

Apex launches new immersive gastronomic event experience in the pharma sector

Specialist pharmaceutical conference and event management company Apex has launched the ultimate immersive gastronomic experience in the UK and global events market.

Precision medicine from concept to clinic

In our latest edition of ‘Perspective’ magazine, we examine the challenges and opportunities for several stakeholders impacted by the dawn of precision medicine

It’s all about the cake/lettuce balance

World Digestive Health Day (WDHD) is held every year on 29 May, so now is the perfect time to redress the nutrition balance

Nucleus Global launches Nucleus POLAR™, a state-of-the-art expert search engine and engagement management tool

Nucleus POLAR™ uses cutting-edge technology to enable rapid external expert identification, mapping and centralised engagement planning.

Lucid Group and Vivid Medical Communications make the cut at this year’s Communiqué awards

Lucid Group has been shortlisted for the Porterhouse Medical Group Award for Medical Consultancy of the Year award, illustrating once again the magic that Lucid brings to the industry.Vivid, a...

Am I wrong to be apprehensive about gene therapy?

Is the introduction of gene therapy going to be smooth sailing? Origin's Strategic Solutions Director, Su Smith, shares her thoughts.